ADAM17 is a major sheddase responsible for EGFR signaling [1,5], which is a widely studied oncogene in head and neck tumors and an potential therapeutic target for OSCC treatment [7,8,36-38]. The gene discussed is EGFR; the disease is head and neck neoplasm.